A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors.
Spyridon GennatasFlorence ChamberlainAlannah M SmrkeJames StewartAndrew HayesLorna RodenChristina MessiouJie-Ying KowaAnna EstivalDharmisha ChauhanKhin ThwayCyril FisherWinette T A van der GraafRobin L JonesCharlotte BensonPublished in: The oncologist (2020)
Single-agent oral vinorelbine is an effective, safe, and well-tolerated treatment for DT. It represents a new oral alternative for management of DT.